Ousubie Jawla

Abstract Multiple doses of HPV vaccines induce durable, antibody-mediated protection against HPV infections and HPV-associated diseases. Although actual protection against disease by a single HPV vaccination dose has not been confirmed in randomised trials, this regimen induces protection against incident and persistent HPV infection, similar to multi-dose schedules. However, the cellular mechanisms driving durable antibody responses to subunit vaccines remain poorly understood.

Loading metrics Open Access Study Protocol Citation: Bashorun AO, Kotei L, Jallow AF, Jawla O, Richard-Ugwuadu EU, Jagana M, et al. (2025) Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocol. PLoS One 20(9): e0332842. https://doi.org/10.1371/journal.pone.0332842 Editor: Katrien G.

Research in context Evidence before this study A PubMed search to identify articles published before June 18, 2023, was conducted with the following search terms with appropriate Boolean operators: “oral poliovirus vaccine”, “vaccine derived poliovirus”, “campaign”, “meta-analysis”, “systematic review”, “randomized controlled trial”, “clinical trial”, “immunogenicity”, “safety”, and “mucosal immunity”.